MAMMÔ 2026 Day 1 Highlights: From Early Detection and Precision Diagnostics to Treatment De-escalation and Global Breast Cancer Care
FDA Approved Atezolizumab Plus Chemotherapy for Stage III dMMR Colon Cancer
Who Shaped Oncology in the First Half of 2026: Breaking Down Approvals by Indications
Enrique Grande: Exploring Long-Term Outcomes and Predictive Biomarkers of Pembrolizumab in Advanced Renal Cell Carcinoma
The Cancer Elimination Collaboration Welcomed Ophira Ginsburg and Dorothy Keefe to the University of Sydney
Bogda Koczwara Named Candidate for UICC Board of Directors 2026–2028
Emanuela Palmerini: Connecting, Learning and Advancing Oncology at OncoDaily Grand Rounds in Madrid
Armenia Grants World's First Marketing Authorizations for BOT+BAL in MSS mCRC
The Community Practice Connections™: Personalized Approaches in NSCLC: Early Detection, Molecular Testing, and Targeted Therapies activity, provided by Physicians’ Education Resource® (PER®), is available on demand from November 25, 2025, […]
The “Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care Models” conference will take place on February 6, 2027, at the Loews Atlanta Hotel in Atlanta, Georgia. […]
The 20th Annual New York GU Cancers Congress®, organized by Physicians’ Education Resource® (PER®), will take place on March 13, 2027, at the Conrad New York Downtown in New York City. Now in its 20th year, the meeting will focus on advances in the management of genitourinary malignancies, including prostate cancer, renal cell carcinoma, and […]
